Literature DB >> 34840909

Pembrolizumab-Induced Parsonage-Turner Syndrome.

Dinesh Keerty1, Edwin Peguero1.   

Abstract

Entities:  

Year:  2021        PMID： 34840909      PMCID： PMC8610514          DOI： 10.1212/CPJ.0000000000000994

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  7 in total

1.  Nivolumab-induced neuralgic amyotrophy with hourglass-like constriction of the anterior interosseous nerve.

Authors:  Michael E Porambo; Kaye E Sedarsky; Emily J Elliott; Brett J Theeler; Jonathan K Smith
Journal:  Muscle Nerve       Date:  2019-03-15       Impact factor: 3.217

2.  Correlation between "hourglass-like fascicular constriction" and idiopathic anterior interosseous nerve palsy.

Authors:  Toru Sunagawa; Yuko Nakashima; Rikuo Shinomiya; Hiroshi Kurumadani; Nobuo Adachi; Mitsuo Ochi
Journal:  Muscle Nerve       Date:  2016-12-23       Impact factor: 3.217

Review 3.  Idiopathic neuralgic amyotrophy in children. A distinct phenotype compared to the adult form.

Authors:  N van Alfen; J Schuuring; B G van Engelen; J J Rotteveel; F J Gabreëls
Journal:  Neuropediatrics       Date:  2000-12       Impact factor: 1.947

4.  Neuralgic amyotrophy: an increasingly diverse entity.

Authors:  J D England; A J Sumner
Journal:  Muscle Nerve       Date:  1987-01       Impact factor: 3.217

5.  Lesion distribution among 281 patients with sporadic neuralgic amyotrophy.

Authors:  Mark A Ferrante; Asa J Wilbourn
Journal:  Muscle Nerve       Date:  2017-02-03       Impact factor: 3.217

Review 6.  Neuralgic amyotrophy: An update on diagnosis, pathophysiology, and treatment.

Authors:  Jeroen J J Van Eijk; Jan T Groothuis; Nens Van Alfen
Journal:  Muscle Nerve       Date:  2016-01-20       Impact factor: 3.217

7.  Neuromuscular complications of immune checkpoint inhibitor therapy.

Authors:  Noah A Kolb; Christopher R Trevino; Waqar Waheed; Fatemeh Sobhani; Kara K Landry; Alissa A Thomas; Mike Hehir
Journal:  Muscle Nerve       Date:  2018-01-17       Impact factor: 3.217
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.